-
My Account
My Account
BSE Live
Apr 23, 16:00Prev. Close
6315.65
Open Price
6295.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 23, 15:59Prev. Close
6323.25
Open Price
6323.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of Procter & Gamble Health (in Rs. Cr.) | Dec '20 | Sep '20 | Jun '20 | Mar '20 | Dec '19 | |
| Net Sales/Income from operations | 240.22 | 263.97 | 201.16 | 228.11 | 236.77 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 240.22 | 263.97 | 201.16 | 228.11 | 236.77 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 46.67 | 93.05 | 52.77 | 64.84 | 73.51 | |
| Purchase of Traded Goods | 4.26 | 5.16 | 2.13 | 7.35 | 1.33 | |
| Increase/Decrease in Stocks | 12.65 | -3.25 | -3.52 | 8.00 | 5.38 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 33.49 | 38.69 | 35.57 | 23.16 | 30.24 | |
| depreciat | 7.85 | 7.36 | 8.05 | 4.24 | 4.28 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 54.40 | 52.22 | 61.11 | 66.03 | 77.29 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 80.90 | 70.74 | 45.04 | 54.50 | 44.74 | |
| Other Income | 5.72 | 6.72 | 10.68 | 10.26 | 6.06 | |
| P/L Before Int., Excpt. Items & Tax | 86.62 | 77.46 | 55.73 | 64.76 | 50.80 | |
| Interest | 0.19 | 0.24 | -- | -- | -- | |
| P/L Before Exceptional Items & Tax | 86.43 | 77.22 | 55.73 | 64.76 | 50.80 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 86.43 | 77.22 | 55.73 | 64.76 | 50.80 | |
| Tax | 18.55 | 17.96 | 6.87 | 18.30 | 12.59 | |
| P/L After Tax from Ordinary Activities | 67.88 | 59.26 | 48.86 | 46.46 | 38.21 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 67.88 | 59.26 | 48.86 | 46.46 | 38.21 | |
| Equity Share Capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 40.90 | 35.70 | 29.40 | 27.99 | 23.02 | |
| Diluted EPS | 40.90 | 35.70 | 29.40 | 27.99 | 23.02 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 40.90 | 35.70 | 29.40 | 27.99 | 23.02 | |
| Diluted EPS. | 40.90 | 35.70 | 29.40 | 27.99 | 23.02 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
01.04.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
12.03.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
09.03.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
25.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
